Company / Accounts Receivable
HARROW, INC. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$110.9M
FY2025
5-year range
$4.5M / $116.4M
FY2021-FY2025
Trend
-4.7%
vs FY2024
Sector context
#53 of 115
Health Care
What the data says
At $111M, HARROW, INC.'s accounts receivable ranks #53 of 115 in the Health Care sector. Improved from $36M to $111M over the past 2 years.
Based on SEC 10-K filings.
$111M in FY2025 with a 5-year CAGR of +110.8%.
Improved from $36M to $111M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +160.8%
- 5-Year CAGR
- +110.8%
- 10-Year CAGR
- -
Sector benchmark
#53 of 115 in Health CareTop 46% of 115This company $110.9M Sector average $1.1B
▼
-90.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +110.8%, indicating consistent growth.
- In FY2025, accounts receivable decreased 4.7% year-over-year.
- Ranks #53 out of 115 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $110.9M | -4.7% |
| FY2024 | $116.4M | +220.9% |
| FY2023 | $36.3M | +480.3% |
| FY2022 | $6.2M | +39.8% |
| FY2021 | $4.5M | +67.9% |
| FY2020 | $2.7M | +32.5% |
| FY2019 | $2.0M | +5.0% |
| FY2018 | $1.9M | +25.2% |
| FY2017 | $1.5M | -47.7% |
| FY2016 | $2.9M | +247.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026